To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

HIV

TODAY'S HEADLINES

5 things to know about the new HIV treatment

By Christine Blank
FDA approved Genvoya, marketed by Gilead Sciences, to treat HIV-1 infection. Here's what you need to know. Read more

Rare metabolic disorder now has new treatment

by Erin Bastick
FDA approved Strensiq (asfotase alfa) as the first approved treatment for perinatal, infantile and juvenile-onset hypophosphatasia (HPP). Read more

CONTINUING EDUCATION

November 2015
Recognition of drug-induced pulmonary disease and management of idiopathic pulmonary fibrosis

Session code: 15DT36-KXF58

This month's CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this activity is to review the common medications associated with pulmonary toxicity and to review how to recognize and treat idiopathic pulmonary fibrosis.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT36-KXF58.
Copy the session code — 15DT36-KXF58  — before logging into the Online CE Center. When the page for the Online CE Center opens, paste the session code into the appropriate field, under your NABP ID.

EDITOR'S PICK

Portal provides diabetes genetic data

by Christine Blank
A new online library or knowledge portal, the Type 2 Diabetes Genetics Beta, has been launched to provide open-access searching of genetic and clinical information on type 2 diabetes. Details

November 18, 2015

Related Articles

[BLOG]: Hepatitis C market competition arrives for 2015

FDA approves drug to treat rare bile acid synthesis disorders in kids, adults

Resources

Get the latest FormularyWatch updates on drug approvals, current studies, and other findings.

Click for the latest Clinical News

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us